E-Book, Englisch, 224 Seiten, Web PDF
Vande Woude / Klein Advances in Cancer Research
1. Auflage 2004
ISBN: 978-0-08-049347-3
Verlag: Elsevier Science & Techn.
Format: PDF
Kopierschutz: 1 - PDF Watermark
E-Book, Englisch, 224 Seiten, Web PDF
ISBN: 978-0-08-049347-3
Verlag: Elsevier Science & Techn.
Format: PDF
Kopierschutz: 1 - PDF Watermark
The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and original reviews on a variety of topics including
Autoren/Hrsg.
Weitere Infos & Material
1;Cover;1
2;Contents;6
3;Contributors to Volume 91;8
4;Chapter 1. Imatinib as a Paradigm of Targeted Therapies;10
4.1;I. Introduction;11
4.2;II. Identification of the BCR-ABL Tyrosine Kinase as a Therapeutic Target;11
4.3;III. Development of an ABL-Specific Tyrosine Kinase Inhibitor;18
4.4;IV. Clinical Trials in CML;20
4.5;V. Mechanisms of Relapse;23
4.6;VI. Structural Basis of ABL Inhibition by Imatinib;26
4.7;VII. Activity of Imatinib in Other Indications;27
4.8;VIII. Lessons Learned from the Clinical Trials of Imatinib;30
4.9;IX. Translating the Success of Imatinib to Other Malignancies;31
4.10;References;32
5;Chapter 2. Prostate Cancer and the Met Hepatocyte Growth Factor Receptor;40
5.1;I. Hepatocyte Growth Factor/Scatter Factor–Met and Stromal–Epithelial Interactions in the Prostate;41
5.2;II. Met in Localized Prostate Cancer;51
5.3;III. Met in Prostate Cancer Metastasis;56
5.4;IV. Therapeutic Implications of Met Expression in Prostate Cancer;60
5.5;References;62
6;Chapter 3. Keratinocyte Growth Factor/Fibroblast Growth Factor 7, a Homeostatic Factor with Therapeutic Potential for Epithelial Protection and Repair;78
6.1;I. Introduction;79
6.2;II. Molecular Biology of KGF;82
6.3;III. Cellular and Molecular Responses to KGF;96
6.4;IV. Signal Transduction;101
6.5;V. Transgenic and Knockout Models;103
6.6;VI. Regenerative and Protective Effects;106
6.7;VII. Clinical Trials. Amelioration of Severe Oral Mucositis;118
6.8;VIII. Concluding Remarks;124
6.9;References;125
7;Chapter 4. Histone Deacetylase Inhibitors;146
7.1;I. Chromatin Structure;147
7.2;II. Histone Deacetylases and Histone Acetyltransferases;147
7.3;III. Histone Deacetylases/Histone Acetyltransferases and Human Cancers;151
7.4;IV. Histone Deacetylase Inhibitors;152
7.5;V. Activity of Histone Deacetylase Inhibitors;156
7.6;VI. Clinical Trials with Histone Deacetylase Inhibitors;161
7.7;VII. Conclusions and Perspectives;168
7.8;References;169
8;Chapter 5. Raf-1 Kinase Inhibitor Protein. Structure, Function, Regulation of Cell Signaling, and Pivotal Role in Apoptosis;178
8.1;I. Introduction. The Phosphatidylethanolamine-Binding Protein Family;179
8.2;II. Raf-1 Kinase Inhibitor Protein;184
8.3;III.Sigficance of rkip in Cancer;203
8.4;IV. Concluding Remarks;205
8.5;References;205
9;Index;210




